rimonabant (Q412529)

Rimonabant (English)

18 November 2016

CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl

1 reference

https://www.whocc.no/atc_ddd_index/?code=A08AX01

Rimonabant (English)

18 November 2016

20 milligram

route of administration

oral administration

1 reference

reference URL

active ingredient in

Acomplia

1 reference

European Medicines Agency product number

EMEA/H/C/000666

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000666/human_med_000623.jsp

https://web.archive.org/web/20170222105742/http://www.ema.europa.eu/ema/index.jsp?curl=pages%2Fmedicines%2Fhuman%2Fmedicines%2F000666%2Fhuman_med_000623.jsp

22 March 2017

archive URL

archive date

22 February 2017

Zimulti

1 reference

European Medicines Agency product number

EMEA/H/C/000691

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000691/human_med_001180.jsp

World Health Organisation international non-proprietary name

22 March 2017

rimonabant (English)

1 reference

Rimonabant (English)

physically interacts with

19 January 2016

cannabinoid receptor 1

subject has role

antagonist

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

G protein-coupled receptor 55

17 August 2016

subject has role

antagonist

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

17 August 2016

mass

462.078 dalton

1 reference

Cannabinoid receptor antagonist

Rimonabant (English)

18 November 2016

1 reference

subject named as (monolingual text)

Medical Subject Headings

15 March 2018

Rimonabant

0 references

Identifiers

J9U entity ID

987007532955705171

Rimonabant (English)

0 references

Library of Congress Authorities ID

sh2007005971

0 references

InChI

InChI=1S/C22H21Cl3N4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)

1 reference

Rimonabant (English)

18 November 2016

2 references

Rimonabant (English)

18 November 2016

ChEBI release 2020-09-01

CAS Registry Number

168273-06-1

2 references

Global Substance Registration System

UNII

RML78EN3XE

rimonabant (English)

18 November 2016

https://commonchemistry.cas.org/detail?cas_rn=168273-06-1

10 April 2021

1 reference

rimonabant (English)

18 November 2016

2 references

Rimonabant (English)

18 November 2016

ChEBI ID

34967

mapping relation type

2 references

RIMONABANT (English)

18 November 2016

International Chemical Identifier

InChI

InChI=1S/C22H21Cl3N4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)

1 reference

RIMONABANT (English)

18 November 2016

2 references

inferred from InChIKey

splash10-03xr-0007900000-a3e664246f26a3081b28

1 reference

0 references

DSSTox substance ID

DTXSID3046453

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

DTXCID1026453

0 references

EC number

685-399-5

0 references

ECHA Substance Infocard ID

100.210.978

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.210.978

27 December 2018

[No public or meaningful name is available] (English)

quotation

CAS no.: 168273-06-1 (English)

1 reference

Rimonabant (English)

publication date

17 November 2015

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

rimonabant (English)

18 November 2016

Rimonabant

0 references

0 references

0 references

1 reference

Human Metabolome Database ID

HMDB0015623

2 references

based on heuristic

inferred from InChIKey

KNApSAcK ID

C00053749

2 references

based on heuristic

inferred from InChIKey

UNII

RML78EN3XE

2 references

Global Substance Registration System

UNII

RML78EN3XE

rimonabant (English)

18 November 2016

0 references

1 reference

1 reference

SR 141716 (English)

3 October 2016

1 reference